Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 453012, 9 pages
http://dx.doi.org/10.1155/2014/453012
Review Article

Breast Cancer Risk in Rheumatoid Arthritis: An Update Meta-Analysis

1School of Health Management, Anhui Medical University, 81 Meishan Road, Hefei, Anhui 230032, China
2The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, Anhui 230022, China
3The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, Anhui 230601, China

Received 27 June 2014; Revised 28 August 2014; Accepted 28 August 2014; Published 27 October 2014

Academic Editor: Hai-Feng Pan

Copyright © 2014 Guo Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Mechanisms of Carcinogenesis in Risk Identification. Iarc Working Group Meeting. Lyon, 11-18 June 1991,” IARC Scientific Publication, vol. 116, pp. 1–608, 1992.
  2. C. M. Vajdic, S. P. McDonald, M. R. E. McCredie et al., “Cancer incidence before and after kidney transplantation,” Journal of the American Medical Association, vol. 296, no. 23, pp. 2823–2831, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Adami, H. Gäbel, B. Lindelöf et al., “Cancer risk following organ transplantation: a nationwide cohort study in Sweden,” The British Journal of Cancer, vol. 89, no. 7, pp. 1221–1227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Smitten, T. A. Simon, M. C. Hochberg, and S. Suissa, “A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis,” Arthritis Research and Therapy, vol. 10, no. 2, article R45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. K. Mercer, R. Davies, J. B. Galloway et al., “Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population,” Rheumatology, vol. 52, no. 1, Article ID kes350, pp. 91–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Yamada, A. Nakajima, E. Inoue et al., “Incidence of malignancy in Japanese patients with rheumatoid arthritis,” Rheumatology International, vol. 31, no. 11, pp. 1487–1492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. J. Chen, Y. T. Chang, C. B. Wang, and C. Y. Wu, “The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan,” Arthritis and Rheumatism, vol. 63, no. 2, pp. 352–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. W. G. Cochran, “The combination of estimates from different experiments,” Biometrics, vol. 10, no. 1, pp. 101–129, 1954. View at Publisher · View at Google Scholar
  10. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Infante-Rivard, G.-E. Rivard, F. Derome et al., “A retrospective cohort study of cancer incidence among patients treated with radiosynoviorthesis,” Haemophilia, vol. 18, no. 5, pp. 805–809, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Parikh-Patel, R. H. White, M. Allen, and R. Cress, “Risk of cancer among rheumatoid arthritis patients in California,” Cancer Causes and Control, vol. 20, no. 6, pp. 1001–1010, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Abásolo, E. Júdez, M. Á. Descalzo, I. González-Álvaro, J. A. Jover, and L. Carmona, “Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a south european population,” Seminars in Arthritis and Rheumatism, vol. 37, no. 6, pp. 388–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Hemminki, X. Li, K. Sundquist, and J. Sundquist, “Cancer risk in hospitalized rheumatoid arthritis patients,” Rheumatology, vol. 47, no. 5, pp. 698–701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Buchbinder, M. Barber, L. Heuzenroeder et al., “Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate,” Arthritis Care and Research, vol. 59, no. 6, pp. 794–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Wolfe and K. Michaud, “Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study,” Arthritis and Rheumatism, vol. 56, no. 9, pp. 2886–2895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Setoguchi, D. H. Solomon, M. E. Weinblatt et al., “Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 54, no. 9, pp. 2757–2764, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Askling, C. M. Fored, L. Brandt et al., “Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists,” Annals of the Rheumatic Diseases, vol. 64, no. 10, pp. 1421–1426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Thomas, D. H. Brewster, R. J. Black, and G. J. Macfarlane, “Risk of malignancy among patients with rheumatic conditions,” International Journal of Cancer, vol. 88, no. 3, pp. 497–502, 2000. View at Google Scholar
  21. J. Cibere, J. Sibley, and M. Haga, “Rheumatoid arthritis and the risk of malignancy,” Arthritis and Rheumatism, vol. 40, no. 9, pp. 1580–1586, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Mellemkjær, M. S. Linet, G. Gridley, M. Frisch, H. Møller, and J. H. Olsen, “Rheumatoid arthritis and cancer risk,” European Journal of Cancer A, vol. 32, no. 10, pp. 1753–1757, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Moritomo, T. Ueda, T. Hiyama, N. Hosono, S. Mori, and Y. Komatsubara, “The risk of cancer in rheumatoid patients in Japan,” Scandinavian Journal of Rheumatology, vol. 24, no. 3, pp. 157–159, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Gridley, J. K. McLaughlin, A. Ekbom et al., “Incidence of cancer among patients with rheumatoid arthritis,” Journal of the National Cancer Institute, vol. 85, no. 4, pp. 307–311, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Tomasoni, G. Remuzzi, and A. Benigni, “Allograft rejection: acute and chronic studies,” Contributions to Nephrology, vol. 159, pp. 122–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. M. Conroy, C. G. Woolcott, K. R. Koga et al., “Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies,” International Journal of Cancer, vol. 130, no. 8, pp. 1915–1924, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Tseng, C. Byrne, K. A. Evers, W. T. London, and M. B. Daly, “Acculturation and breast density in foreign-born, U.S. Chinese women,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 7, pp. 1301–1305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Ursin, H. Ma, A. H. Wu et al., “Mammographic density and breast cancer in three ethnic groups,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 4, pp. 332–338, 2003. View at Google Scholar · View at Scopus
  30. N. A. Bhowmick, E. G. Neilson, and H. L. Moses, “Stromal fibroblasts in cancer initiation and progression,” Nature, vol. 432, no. 7015, pp. 332–337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. Mueller and N. E. Fusenig, “Friends or foes—bipolar effects of the tumour stroma in cancer,” Nature Reviews Cancer, vol. 4, no. 11, pp. 839–849, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Sugimoto, T. M. Mundel, M. W. Kieran, and R. Kalluri, “Identification of fibroblast heterogeneity in the tumor microenvironment,” Cancer Biology and Therapy, vol. 5, no. 12, pp. 1640–1646, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Drygin, C. B. Ho, M. Omori et al., “Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer,” Biochemical and Biophysical Research Communications, vol. 415, no. 1, pp. 163–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G.-J. Zhang and I. Adachi, “Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma,” Anticancer Research, vol. 19, no. 2, pp. 1427–1432, 1999. View at Google Scholar · View at Scopus
  35. Y. Li, X. Ma, J. Zhao et al., “Microrna-210 as a prognostic factor in patients with breast cancer: meta-analysis,” Cancer Biomark, vol. 13, no. 6, pp. 471–481, 2013. View at Google Scholar
  36. T. Pietras, J. Szemraj, M. Panek et al., “Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients,” Molecular Biology Reports, vol. 39, no. 3, pp. 2163–2167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. B. Glinskii, J. Ma, S. Ma et al., “Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders,” Cell Cycle, vol. 8, no. 23, pp. 3925–3942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. X. F. Sun and H. Zhang, “NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases,” Histology and histopathology, vol. 22, no. 12, pp. 1387–1398, 2007. View at Google Scholar · View at Scopus
  39. S. M. Hill, S. A. W. Fuqua, G. C. Chamness, G. L. Greene, and W. L. McGuire, “Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism,” Cancer Research, vol. 49, no. 1, pp. 145–148, 1989. View at Google Scholar · View at Scopus
  40. T. Ushiyama, K. Mori, K. Inoue, J. Huang, J. Nishioka, and S. Hukuda, “Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 58, no. 1, pp. 7–10, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. D. M. Dick, “Gene-environment interaction in psychological traits and disorders,” Annual Review of Clinical Psychology, vol. 7, pp. 383–409, 2011. View at Publisher · View at Google Scholar · View at Scopus